Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
The AAPS Journal|February 14, 2013
Modeling NSCLC progression: recent advances and opportunities availableAhmed Abbas Suleiman, Lucia Nogova, Uwe FuhrDrug Metabolism and Pharmacokinetics|November 30, 2015
Population pharmacokinetic and pharmacodynamic modeling of epinephrine administered using a mobile inhalerSebastian Frechen, Ahmed Abbas Suleiman, Ali Mohammad Nejad Sigaroudi, et al.Clinical Pharmacology and Therapeutics|December 19, 2022
Population Pharmacokinetic and Exposure-Response Analyses for Efficacy and Safety of Risankizumab in Patients With Active Crohn's DiseaseAhmed Abbas Suleiman, Aline Goebel, Sumit Bhatnagar, et al.Journal of Clinical Pharmacology|December 28, 2020
A Population Pharmacokinetic Model of (R)- and (S-) Oxybutynin and Its Active Metabolites After Oral and Intravesical Administration to Healthy VolunteersMelanie Kretschmar, Ahmed Abbas Suleiman, Petra Krause, et al.CPT: Pharmacometrics & Systems Pharmacology|September 18, 2020
Exposure-Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis-Associated PainAhmed Abbas Suleiman, Ahmed Nader, Insa Winzenborg, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 17, 2014
Modeling tumor dynamics and overall survival in advanced non-small-cell lung cancer treated with erlotinibAhmed Abbas Suleiman, Sebastian Frechen, Matthias Scheffler, et al.The AAPS Journal|August 20, 2015
A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer PatientsAhmed Abbas Suleiman, Sebastian Frechen, Matthias Scheffler, et al.Clinical Pharmacokinetics|May 9, 2013
A semiphysiological population pharmacokinetic model for dynamic inhibition of liver and gut wall cytochrome P450 3A by voriconazoleSebastian Frechen, Lisa Junge, Teijo I Saari, et al.Journal of Clinical Pharmacology|May 1, 2014
Population pharmacokinetic analysis of circadian rhythms in hepatic CYP3A activity using midazolamDorota Tomalik-Scharte, Ahmed Abbas Suleiman, Sebastian Frechen, et al.Journal of Clinical Pharmacology|September 14, 2019
Population Pharmacokinetics of Glecaprevir/Pibrentasvir in HCV-infected Japanese Subjects in Phase 3 CERTAIN-1 and CERTAIN-2 TrialsAhmed Abbas Suleiman, Chih-Wei Lin, Wei Liu, et al.Pageof 2